Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Opioid settlement funds news and resources
Related news about the opioid crisis and improving patient outcomes
Download the eBook to learn how the technology has advanced and why it represents the best available mode for patient care today
Use this cognitive checklist to identify reversible threats, broaden your differential and avoid tunnel vision when assessing patients with altered mental status
Look for tampered packaging, excessive use and false documentation to identify a drug diversion in your EMS agency
The University of Florida Police Department said Danny Taylor Tate, 30, became combative as responders tried to arrange safe care for his 6-year-old son
Albuquerque Fire Rescue responded to nearly 3,000 overdoses in a year as crews increasingly rely on Narcan to revive patients amid New Mexico’s opioid crisis
Richmond Ambulance Authority reported overdose calls fell from 1,991 in 2022 to 1,042 in 2025 as officials point to naloxone access, education and recovery outreach
Honolulu EMS responded to two clusters of suspected overdoses within an hour, with five patients requiring multiple doses of naloxone before being hospitalized in serious condition
The Anthony Giambrone case exposes the widening gap between drug-free workplace rules, medical marijuana laws and what it actually means to be fit for duty.
Pennsylvania’s program distributing naloxone and drug testing strips added its first faith-based recovery partner as officials report more than 17,600 overdose reversals statewide
Officials point to expanded Narcan access, treatment, community paramedicine and coordinated public safety efforts as contributing to the decline
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.